OncoCyte Corporation Gains 28.99%
Fri, Dec 23, 2022 at 07:06 PM
OncoCyte Corporation (OCX:NASDAQ) jumped higher at $0.38, representing a gain of 29%. The stock got featured on our News Catalysts scanner on Fri, Dec 16, 2022 at 08:54 AM in the 'INVESTOR UPDATE' category. From Fri, Dec 09, 2022, the stock recorded 30.00% Up Days and 27.27% Green Days
The stock spiked on Tue, Aug 30, 2022 at $1.1 with a volume of 5M+.
About OncoCyte Corporation (OCX:NASDAQ)
OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.
Top 10 Gainers:
- Expion360 Inc. (XPON:NASDAQ), 139.82%
- Larkspur Health Acquisition Corp. (LSPR:NASDAQ), 132.68%
- Akso Health Group (AHG:NASDAQ), 100.55%
- Starry Group Holdings Inc. Class A (STRY:NYSE), 66.32%
- Elys Game Technology Corp. (ELYS:NASDAQ), 45.38%
- AMC Entertainment Holdings Inc. Preferred Equity Units each constituting a depositary share representing a 1/100th interest in a share of Series A Convertible P (APE:NYSE), 44.17%
- Mobile Global Esports Inc. (MGAM:NASDAQ), 32.04%
- WaveDancer Inc. (WAVD:NASDAQ), 31.04%
- Argo Blockchain plc (ARBK:NASDAQ), 30.83%
- OncoCyte Corporation (OCX:NASDAQ), 28.99%